(2) Topical ocular diagnostic pharmaceutical agents may be used only by optometrists who have established a plan approved by the secretary after consultation with the examining board and the medical examining board for the referral of patients who experience adverse reactions from the application of such agents to appropriate medical services.
(3) Topical ocular diagnostic pharmaceutical agents may be used only by optometrists who successfully complete an examination conducted by the examining board on the subject of general and ocular pharmacology as it relates to optometry with particular emphasis on the use of topical ocular diagnostic pharmaceutical agents, including the treatment of any adverse reactions that may occur. The examination shall be prepared or approved by the department in consultation with the examining board, the medical examining board and the pharmacy examining board. The department shall periodically review the validity, reliability and appropriateness of the examination. In regard to the examination, the department may:
(a) Prepare, administer and grade the examination;
(b) Approve in whole or in part an examination prepared, administered and graded by the national board of examiners in optometry or by the optometry examining board; or
(c) Approve and administer an examination prepared and graded by or under the direction of the national board of examiners in optometry.
(4) In addition to the requirements of sub. (3) , optometrists who wish to use topical ocular diagnostic pharmaceutical agents shall successfully complete 60 classroom hours of study in general and ocular pharmacology as it relates to optometry with particular emphasis on the use of topical ocular diagnostic pharmaceutical agents. At least 30 of the 60 classroom hours of study shall be in ocular pharmacology and shall emphasize the systemic effects of and reactions to pharmaceutical agents, including the treatment of any adverse reactions that may occur. The course of study shall be offered by an institution approved by the secretary and accredited by a regional or professional accrediting organization which is recognized by the council on post-secondary accreditation and the U.S. office of education and shall be completed prior to entering the examination required by sub. (3) .
(5) The secretary shall, after consultation with the examining board, the medical examining board and the pharmacy examining board, promulgate rules specifying the topical ocular diagnostic pharmaceutical agents which optometrists may utilize in this state.
(6) The department shall certify optometrists who meet the requirements in this section.
(7) No fee may be charged for a certificate issued under this section. A certificate issued under this section remains in effect while the optometrist's license to practice optometry remains in effect unless the certificate is suspended or revoked by the department.
(8) No optometrist may be reimbursed under s. 49.46 (2) (a) 3. for any increase in charges or separate charge which is attributable to the use of topical ocular diagnostic pharmaceutical agents.